ABVC BioPharma, Inc. Proceeds from Issuance of Private Placement
ABVC BioPharma, Inc. (ABVC) reported Proceeds from Issuance of Private Placement of $3.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-03-03
- ABVC BioPharma, Inc. proceeds from issuance of private placement for the quarter ending 2025-12-31 was $528.18K.
- ABVC BioPharma, Inc. proceeds from issuance of private placement for the quarter ending 2025-09-30 was $908.37K.
- ABVC BioPharma, Inc. proceeds from issuance of private placement for fiscal 2025 was $3.31M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $528.18K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $1.44M derived: sum of 2 quarters · filed 2026-03-03 | $3.31M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $908.37K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $2.78M 10-Q/A · filed 2026-03-03 | ||
| 2025-06-30 | $1.87M 10-Q · filed 2025-08-13 | |||
| 2024-09-30 | $164.77K 10-Q/A · filed 2026-03-03 |